COVID-19 and Cirrhosis: A Combination We Must Strive to Prevent

Overview

Journal Gastroenterology

Specialty Gastroenterology

Date 2021 Aug 28

PMID 34453892

Citations 5

Authors

Feng Su

Affiliations

Soon will be listed here.

Citing Articles

COVID-19, Possible Hepatic Pathways and Alcohol Abuse-What Do We Know up to 2023?.

Michalak A, Lach T, Szczygiel K, Cichoz-Lach H Int J Mol Sci. 2024; 25(4).

PMID: 38396888 PMC: 10888568. DOI: 10.3390/ijms25042212.

Evaluation of the effects of the pandemic period on cirrhosis patients.

Karaali R, Bora E, Topal F Prz Gastroenterol. 2023; 18(3):320-326.

PMID: 37937105 PMC: 10626387. DOI: 10.5114/pg.2023.131393.

Risk of New-Onset Liver Injuries Due to COVID-19 in Preexisting Hepatic Conditions-Review of the Literature.

Bucurica S, Radu F, Bucurica A, Socol C, Prodan I, Tudor I Medicina (Kaunas). 2023; 59(1).

PMID: 36676691 PMC: 9864905. DOI: 10.3390/medicina59010062.

Liver injury in COVID-19: A minireview.

Hu W, Jiang F, Shu W, Zhao R, Cao J, Wang D World J Gastroenterol. 2023; 28(47):6716-6731.

PMID: 36620342 PMC: 9813934. DOI: 10.3748/wjg.v28.i47.6716.

COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status.

Cao Z, Zhang C, Zhao S, Sheng Z, Xiang X, Li R Infect Dis Poverty. 2022; 11(1):56.

PMID: 35578350 PMC: 9108345. DOI: 10.1186/s40249-022-00982-0.

References

Mahmud N, Kaplan D, Goldberg D, Taddei T, Serper M . Changes in Hepatocellular Carcinoma Surveillance and Risk Factors for Noncompletion in the Veterans Health Administration Cohort During the Coronavirus Disease 2019 Pandemic. Gastroenterology. 2021; 160(6):2162-2164.e3. PMC: 8142896. DOI: 10.1053/j.gastro.2021.01.007. View

Mahmud N, Hubbard R, Kaplan D, Serper M . Declining Cirrhosis Hospitalizations in the Wake of the COVID-19 Pandemic: A National Cohort Study. Gastroenterology. 2020; 159(3):1134-1136.e3. PMC: 7200325. DOI: 10.1053/j.gastro.2020.05.005. View

Albillos A, Lario M, Alvarez-Mon M . Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol. 2014; 61(6):1385-96. DOI: 10.1016/j.jhep.2014.08.010. View

Khan A, Bilal M, Morrow V, Cooper G, Thakkar S, Singh S . Impact of the Coronavirus Disease 2019 Pandemic on Gastrointestinal Procedures and Cancers in the United States: A Multicenter Research Network Study. Gastroenterology. 2021; 160(7):2602-2604.e5. PMC: 7919513. DOI: 10.1053/j.gastro.2021.02.055. View

Ioannou G, Liang P, Locke E, Green P, Berry K, OHare A . Cirrhosis and Severe Acute Respiratory Syndrome Coronavirus 2 Infection in US Veterans: Risk of Infection, Hospitalization, Ventilation, and Mortality. Hepatology. 2020; 74(1):322-335. PMC: 7753324. DOI: 10.1002/hep.31649. View

Ge J, Pletcher M, Lai J . Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study. Gastroenterology. 2021; 161(5):1487-1501.e5. PMC: 8286237. DOI: 10.1053/j.gastro.2021.07.010. View

Marjot T, Moon A, Cook J, Abd-Elsalam S, Aloman C, Armstrong M . Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study. J Hepatol. 2020; 74(3):567-577. PMC: 7536538. DOI: 10.1016/j.jhep.2020.09.024. View

John B, Deng Y, Scheinberg A, Mahmud N, Taddei T, Kaplan D . Association of BNT162b2 mRNA and mRNA-1273 Vaccines With COVID-19 Infection and Hospitalization Among Patients With Cirrhosis. JAMA Intern Med. 2021; 181(10):1306-1314. PMC: 8278308. DOI: 10.1001/jamainternmed.2021.4325. View

Kim D, Adeniji N, Latt N, Kumar S, Bloom P, Aby E . Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study. Clin Gastroenterol Hepatol. 2020; 19(7):1469-1479.e19. PMC: 7497795. DOI: 10.1016/j.cgh.2020.09.027. View

10.

Adeniji N, Carr R, Aby E, Catana A, Wegermann K, Dhanasekaran R . Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities With Chronic Liver Diseases. Gastroenterology. 2020; 160(4):1406-1409.e3. PMC: 7677694. DOI: 10.1053/j.gastro.2020.11.035. View

11.

Singh S, Khan A . Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Among Patients With Preexisting Liver Disease in the United States: A Multicenter Research Network Study. Gastroenterology. 2020; 159(2):768-771.e3. PMC: 7196546. DOI: 10.1053/j.gastro.2020.04.064. View

12.

Bajaj J, Garcia-Tsao G, Biggins S, Kamath P, Wong F, McGeorge S . Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort. Gut. 2020; 70(3):531-536. PMC: 7371484. DOI: 10.1136/gutjnl-2020-322118. View